NCT03233451 is a NA clinical trial of Psycho-behavioral intervention in Depression, sponsored by Peking University.

Who is sponsoring NCT03233451?

NCT03233451 is sponsored by Peking University.

What drugs are being tested in NCT03233451?

Interventions in NCT03233451: Psycho-behavioral intervention.

What condition does NCT03233451 study?

NCT03233451 studies Depression.

Is NCT03233451 still recruiting?

NCT03233451 is currently status unknown. Last updated 9 April 2019.

Last reviewed 2019-04-09 · How we verify

NCT03233451

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psycho-behavioral Intervention for Depression in Chronic Heart Failure

Status unknown NA Last updated 9 April 2019

What this trial tests

NA trial testing Psycho-behavioral intervention in Depression in 236 participants. Status unknown.

Timeline

1 August 2017

Primary endpoint
30 December 2019

31 December 2020

Quick facts

Lead sponsor	Peking University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	236
Start date	1 August 2017
Primary completion	30 December 2019
Estimated completion	31 December 2020
Sites	6 locations across China

Drugs / interventions tested

Psycho-behavioral intervention

Conditions studied

Depression — all drugs for Depression →

Sponsor

Peking University

Who can join

Adults 60 to 85, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to explore the effectiveness of psycho-behavioral intervention on depressive symptoms among older adults with chronic heart failure. Meanwhile, the effect on cardiac function and quality of life will also be explored.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Behavioural activation therapy for depression in adults with non-communicable diseases.
Uphoff E, Pires M, Barbui C, Barua D, et al · · 2020 · cited 24× · PMID 32841367 · DOI 10.1002/14651858.cd013461.pub2
Effectiveness of a telephone-delivered psycho-behavioural intervention on depression in elderly with chronic heart failure: rationale and design of a randomized controlled trial.
Zhang Y, Lv X, Jiang W, Zhu Y, et al · · 2019 · cited 9× · PMID 31132996 · DOI 10.1186/s12888-019-2135-2

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Peking University trials

Trials by the same sponsor.

NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03233451 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University
Last refreshed: 9 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03233451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing